Sanofi Genzyme competitorsClear all

Sanofi Genzyme's top competitors include Amgen, Shire, Amicus Therapeutics and Biogen.
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is engaged in the development of human therapeutic products.
Shire
Shire
Shire is a specialty biopharmaceutical company.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Founding Date
Founding Date
1981
Founding Date
1980
Founding Date
1986
Founding Date
2002
Founding Date
1978
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Thousand Oaks, US HQ
Ben Aknoun, DZ
Kew, AU
North Ryde, AU
Wien, AT
Sint Lambrechts Woluwe, BE
see more
Locations
Dublin, IE HQ
The Rocks, AU
Wien, AT
Bruxelles, BE
Sofia, BG
see more
Locations
Cranbury Township, US HQ
Northbridge, AU
Pointe Claire, CA
Courbevoie, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Employees
Employees
N/A
Employees
21,5003% increase
Employees
23,044
Employees
50856% increase
Employees
7,8007% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
107.1 b
Valuation ($)
54.8 b
Valuation ($)
2.6 b
Valuation ($)
44.3 b
Twitter followers
Twitter followers
54.1 k
Twitter followers
80.9 k
Twitter followers
7.7 k
Twitter followers
1.4 k
Twitter followers
27.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
28
Number of tweets (last 30 days)
95
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
44
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
8.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
20.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
96.43%
Percentage of tweets with engagement (last 30 days)
93.68%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
588008
Alexa Website Rank
269127
Alexa Website Rank
333836
Alexa Website Rank
396593
Alexa Website Rank
83540

Financial

Revenue (est.)
Revenue (est.)
$5b (Y, 2017)
Revenue (est.)
$23.7b (FY, 2018)
Revenue (est.)
£43m (FY, 2018)
Revenue (est.)
$91.2m (FY, 2018)
Revenue (est.)
$11.4b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
$4.1b (FY, 2018)
Cost of goods
N/A
Cost of goods
$14.4m (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$19.6b (FY, 2018)
Gross profit
N/A
Gross profit
$76.8m (FY, 2018)
Gross profit
N/A
Net income
Net income
N/A
Net income
$8.4b (FY, 2018)
Net income
£3.4m (FY, 2018)
Net income
($349m) (FY, 2018)
Net income
$3.7b (FY, 2016)

Operating

Countries
Countries
100 (Sep, 2018)
Countries
N/A
Countries
100 (FY, 2017)
Countries
N/A
Countries
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
N/A
Total funding raised
$ 88m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Amgen
HQ
Thousand Oaks, US
Employees
21,500↑ 3% increase

Amgen (formerly known as Applied Molecular Genetics) is engaged in the development of human therapeutic products.

View company
Shire
HQ
Dublin, IE
Employees
23,044

Shire is a specialty biopharmaceutical company.

View company
Amicus Therapeutics
HQ
Cranbury Township, US
Employees
508

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Biogen
HQ
Cambridge, US
Employees
7,800↑ 7% increase

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company